Balance Sheet
Cash Flow Statement
AmortizationAmortizationChange in Account PayablesChange in Account PayablesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionGains from Investment SecuritiesGains from Investment SecuritiesNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Gains from Investment Securities (2021)

Bioceres Crop Solutions' Gains from Investment Securities history spans 1 years, with the latest figure at $12.7 million for Q4 2021.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $12.7 million in Q4 2021 year-over-year; TTM through Dec 2021 was $12.7 million, a N/A change, with the full-year FY2025 number at -$7.8 million, down 6078.12% from a year prior.
  • Gains from Investment Securities hit $12.7 million in Q4 2021 for Bioceres Crop Solutions.
  • Over the last five years, Gains from Investment Securities for BIOX hit a ceiling of $12.7 million in Q4 2021 and a floor of $12.7 million in Q4 2021.